Ritenour Paul MD - Mansfield, Ohio 44907

Ritenour Paul MD is categorized under Doctors in Mansfield, OH .

Business Name: Ritenour Paul MD
Contact Person: Paul Ritenour
Address: 370 Cline Avenue # B3, Mansfield, Ohio 44907
Phone Number: (419) 756-9995
Website Address: ahni.com
Annual Revenue (USD): $100.000 to $499.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:
Related Businesses: Vein Care Institute of Ohio - Mansfield, OH 44907
Andrews Dana H MD - Mansfield, OH 44907
Miller William J MD - Mansfield, OH 44907
Vadada Veera P MD - Mansfield, OH 44907
Sansait Nicomedes M MD - Mansfield, OH 44907
Davis Keith L MD - Mansfield, OH 44907
Barkett Jr Robert E MD - Mansfield, OH 44907
Moritz Deborah L MD - Mansfield, OH 44907
Schnitzer David B MD - Mansfield, OH 44907
Danals Laura MD - Mansfield, OH 44907
Exten Robert MD - Mansfield, OH 44907
Ohio Vein Clinic - Mansfield, OH 44907
Isaac Mark T MD - Mansfield, OH 44907
Ortega-Carr Debora MD - Mansfield, OH 44907
Craske III W Donald DO - Mansfield, OH 44907
Vadada Padmini MD - Mansfield, OH 44907
Sringeri V MD - Mansfield, OH 44907
Rancitelli Philip MD - Mansfield, OH 44907
Sethi Sushil M MD - Mansfield, OH 44907
Bergese Jorge J MD - Mansfield, OH 44907

The company Ritenour Paul MD provides B2C services in the form of Doctors from its single location in Ohio. 1 to 4 employees work for Ritenour Paul MD, and the business now earns $100.000 to $499.999 per annum.

Ritenour Paul MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 . To contact Ritenour Paul MD, please call Paul Ritenour with the phone number (419) 756-9995 or visit its single location at 370 Cline Avenue # B3 in Mansfield, Ohio 44907.

The location of the single location can also be found using the coordinates 40.74749,-82.52889. Read more details about this business on the webpage ahni.com or follow the company’s social media accounts, on Twitter and on Facebook.